AstraZeneca
led small molecule discovery is driving efficacy of small molecule projects are applying approaches | AstraZeneca
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
20 of 86
Related slides by other companies
Recursion Pharmaceuticals
Investor Day
January 2023
clinical is recursion small molecule to reach the clinic selective inhibitor of toxins | Recursion Pharmaceuticals
Recursion Pharmaceuticals
Investor Day
January 2023
clinical is recursion small molecule to reach the clinic selective inhibitor of toxins | Recursion Pharmaceuticals
Exscientia
Investor Presentation
August 2023
data and model agnostic | Exscientia
Vigil Neuroscience
IPO
January 2022
novel small molecule agonist program vigil | Vigil Neuroscience
Other recent decks by AstraZeneca
See all presentations (31 decks)
Results
February 2025
Results
November 2024
Results
November 2024
Investor Event
September 2024
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights